Latest Blogs

Mar 03, 2021
"2020 will be a year we at CancerLinQ look back on with mixed emotion because, in the midst of the pandemic, we achieved a momentous milestone," said Dr. Danielle Potter.
Mar 02, 2021
"Leading right now means helping team members adapt to the losses that all have experienced and supporting them with more than exhortation and reassurance," writes Dr. Mark E. Robson.
Feb 23, 2021
In their roles as patient advocates, Ms. Janine Guglielmino and Dr. Sue Friedman have observed growing patient confusion about breast cancer subtypes and the difference between acquired and inherited gene mutations.
Feb 18, 2021
This is a time of significant and multi-layered anxiety, especially for our patients living with and beyond cancer. 
Subscribe to this column

Don S. Dizon, MD, FACP, FASCO

Don S. Dizon, MD, FACP, FASCO, is a professor of medicine at Brown University, director of the Breast and Pelvic Malignancies Program and Hematology-Oncology Outpatient Clinics at Lifespan Cancer Institute, and director of Medical Oncology and the Sexual Health First Responders Clinic at Rhode Island Hospital. Dr. Dizon has served as past chair of ASCO's Social Media Working Group and the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the JCO Oncology Practice Editorial Board, and editor in chief of the ASCO Educational BookFollow Dr. Dizon across social media channels @drdonsdizon. 

Disclosure.

Sep 24, 2011
I have followed with interest the exciting progress being made across oncology--progress in melanoma with the anti-CTLA agent iplimumab and the BRAF inhibitor,...
Sep 11, 2011
I recently gave Grand Rounds at Women & Infants’ Hospital--a women’s specialty hospital that provides some of the best care for obstetrics/gynecology in the region. It is also the home to my specialized program for women with breast and gynecologic malignancies.  I spoke on delivering bad news...
Aug 14, 2011
One of the interests I have developed over time is in the arena of cancer survivorship, specifically female sexual heath after cancer and its treatment. Having worked at Memorial Sloan-Kettering both as a fellow and as a junior faculty member, I worked closely with colleagues in Gynecology,...
Jul 19, 2011
I recently returned from the semi-annual meeting of the Gynecologic Oncology Group, where the charge is to develop and test new treatment strategies in gynecologic malignancies. In the time I have been involved with the group, I have witnessed paradigm shifts in...

Pages